Prospective Validation of the Emergency Heart Failure Mortality Risk Grad for Acute Heart Failure: The Acute Congestive Heart Failure Urgent Care Evaluation (ACUTE) Study.
Circulation. 2018 Nov 29;:
Authors: Lee DS, Lee JS, Schull MJ, Borgundvaag B, Edmonds ML, Ivankovic M, McLeod SL, Dreyer JF, Sabbah S, Levy PD, O'Neill T, Chong A, Stukel TA, Austin PC, Tu JV
BACKGROUND: Improved risk stratification of acute heart failure in the emergency department may inform physicians' decisions regarding patient admission or early discharge disposition. We aimed to validate the previously-derived Emergency Heart failure Mortality Risk Grade for 7-day (EHMRG7) and 30-day (EHMRG30-ST) mortality.
METHODS: We conducted a multicenter, prospective validation study of patients with acute heart failure at 9 hospitals. We surveyed physicians for their estimates of 7-day mortality risk, obtained for each patient prior to knowledge of the model predictions, and compared these with EHMRG7 for discrimination and net reclassification improvement. We also prospectively examined discrimination of the EHMRG30-ST model, which incorporates all components of EHMRG7 as well as the presence of ST-depression on the 12-lead electrocardiogram.
RESULTS: We recruited 1983 patients seeking emergency department care for acute heart failure. Mortality rates at 7 days in the five risk groups; very low, low, intermediate, high, and very high risk, were: 0%, 0%, 0.6%, 1.9%, and 3.9% respectively. At 30 days, the corresponding mortality rates were: 0%, 1.9%, 3.9%, 5.9%, and 14.3%. Compared to physician-estimated risk of 7-day mortality (PER7, c-statistic 0.71; 95% confidence interval [CI] 0.64, 0.78) there was improved discrimination with EHMRG7 (c-statistic 0.81; 95%CI 0.75, 0.87, p = 0.022 vs. PER7) and with EHMRG7 combined with physicians' estimates (c-statistic 0.82; 95%CI 0.76, 0.88, p = 0.003 vs. PER7). Model discrimination increased non-significantly, by 0.014 (95%CI -0.009, 0.037) when physicians' estimates combined with EHMRG7 were compared to EHMRG7 alone (p = 0.242). The c-statistic for EHMRG30-ST alone was 0.77 (95%CI 0.73, 0.81) and 30-day model discrimination increased non-significantly by addition of physician-estimated risk to 0.78 (95%CI; 0.73, 0.82, p = 0.187). Net reclassification improvement with EHMRG7 was 0.763 (95%CI; 0.465, 1.062) when assessed continuously and 0.820 (0.560, 1.080) using risk categories compared to PER7.
CONCLUSIONS: A clinical model allowing simultaneous prediction of mortality at both 7 and 30 days identified acute heart failure patients with a low risk of events. Compared to physicians' estimates, our multivariable model was better able to predict 7-day mortality, and may guide clinical decisions.
CLINICAL TRIAL REGISTRATION: URL: https://clinicaltrials.gov Unique Identifier: NCT02634762.
PMID: 30586748 [PubMed - as supplied by publisher]